Prednisone Dosing for Pediatric Acute Urticaria
For pediatric patients with acute urticaria (hives), oral prednisone is NOT routinely recommended as first-line therapy, but when used, the dose is 1 mg/kg/day (maximum 60 mg) for 3-5 days.
Primary Treatment Approach
The most recent international guideline on urticaria management 1 establishes that second-generation H1-antihistamines are the first-line treatment for urticaria in children, not corticosteroids. Systemic corticosteroids should only be considered as a restricted measure in children with acute urticaria.
When Corticosteroids Are Considered
If corticosteroids are deemed necessary for severe acute urticaria unresponsive to antihistamines:
Dosing Regimen
- Dose: 1 mg/kg/day oral prednisone (or prednisolone equivalent)
- Maximum: 60 mg/day
- Duration: 3-5 days (short burst)
- Timing: Single morning dose before 9 AM 2
- Administration: With food or milk to reduce gastric irritation 2
Evidence Base
The evidence for adding corticosteroids to antihistamines in acute urticaria is conflicting and of low quality:
Against routine use:
- A 2018 randomized trial 3 found that adding prednisone 40 mg for 4 days to levocetirizine provided no additional benefit over levocetirizine alone in adults with acute urticaria
- A 2024 systematic review 4 showed that in 2 of 3 RCTs, adding prednisone to antihistamines did not improve symptoms compared to antihistamine alone
- A 2025 evidence-based review 5 concluded that the benefit of systemic corticosteroids in uncomplicated acute urticaria remains unclear
Supporting limited use:
- A 1995 trial 6 showed prednisone 20 mg twice daily for 4 days added to antihistamines improved symptoms, but this was in adults
- A 2024 meta-analysis 7 found corticosteroids likely improve urticaria activity by 14-15% in patients with low-to-moderate antihistamine response, but also increase adverse events by 15%
Pediatric-Specific Considerations
Dosing Evidence from Other Conditions
While not specific to urticaria, pediatric prednisone dosing patterns from other acute conditions provide context:
- Acute asthma: 1 mg/kg/day for 3 days is non-inferior to 2 mg/kg/day and causes less vomiting 8
- General pediatric dosing: FDA labeling indicates 5-60 mg/day range depending on condition severity 2
Safety Concerns
- Avoid prolonged use: Risk of growth suppression, HPA axis suppression, and Cushingoid effects 2
- Common side effects: Vomiting (dose-dependent), behavioral changes, increased appetite
- Taper not needed: For short courses ≤5 days, abrupt discontinuation is acceptable
Clinical Algorithm
Step 1: Start with second-generation H1-antihistamine (cetirizine, loratadine, or levocetirizine) 1
Step 2: If inadequate response and severe symptoms with significant quality of life impact:
- Consider adding prednisone 1 mg/kg/day (max 60 mg) for 3-5 days
- Give as single morning dose with food
Step 3: Reassess in 24-48 hours
- If improving: Complete short course, no taper needed
- If not improving: Consider alternative diagnosis or specialist referral
Important Caveats
⚠️ Do NOT use corticosteroids if:
- Urticaria is mild and responding to antihistamines alone
- Patient has contraindications (active infection, diabetes, immunosuppression)
- Angioedema involves airway (requires emergency management with epinephrine)
⚠️ Common pitfall: Prescribing unnecessarily long courses (>5 days) or high doses (>1 mg/kg/day) increases adverse effects without additional benefit 8, 7
⚠️ Anaphylaxis distinction: If urticaria occurs with systemic symptoms (hypotension, respiratory distress), this is anaphylaxis requiring epinephrine 0.01 mg/kg IM (max 0.3 mg), not just corticosteroids 9